Found: 42
Select item for more details and to access through your institution.
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210415
- By:
- Publication type:
- Article
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12260-3
- By:
- Publication type:
- Article
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2423186, doi. 10.1001/jamanetworkopen.2024.23186
- By:
- Publication type:
- Article
Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all.
- Published in:
- Asian Journal of Andrology, 2014, v. 16, n. 6, p. 807, doi. 10.4103/1008-682X.137680
- By:
- Publication type:
- Article
Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities.
- Published in:
- Research & Reports in Urology, 2018, v. 10, p. 205, doi. 10.2147/RRU.S154932
- By:
- Publication type:
- Article
Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer.
- Published in:
- Prostate Cancer (20903111), 2013, p. 1, doi. 10.1155/2013/981684
- By:
- Publication type:
- Article
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 3741, doi. 10.2147/CMAR.S202973
- By:
- Publication type:
- Article
Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 9, p. 1201, doi. 10.1007/s11912-022-01269-1
- By:
- Publication type:
- Article
Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting.
- Published in:
- Prostate, 2024, v. 84, n. 9, p. 888, doi. 10.1002/pros.24696
- By:
- Publication type:
- Article
Impact of androgen receptor alterations on cell‐free DNA genomic profiling on survival outcomes in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 16, p. 1602, doi. 10.1002/pros.24618
- By:
- Publication type:
- Article
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 450, doi. 10.1093/oncolo/oyae030
- By:
- Publication type:
- Article
Impact of Time to Metastasis (Synchronous vs. Metachronous) on Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with First Line Immune-Checkpoint Inhibitors (ICI)-based Combinations.
- Published in:
- Oncologist, 2023, v. 28, p. S9, doi. 10.1093/oncolo/oyad216.014
- By:
- Publication type:
- Article
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 737, doi. 10.1093/oncolo/oyad019
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. e815, doi. 10.1093/oncolo/oyac176
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. e815, doi. 10.1093/oncolo/oyac176
- By:
- Publication type:
- Article
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1006, doi. 10.1002/onco.13949
- By:
- Publication type:
- Article
Identification of Somatic Gene Signatures in Circulating Cell‐Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 751, doi. 10.1002/onco.13869
- By:
- Publication type:
- Article
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. e270, doi. 10.1002/onco.13601
- By:
- Publication type:
- Article
A Phase I Study of Alpha‐1,3‐Galactosyltransferase‐Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 121, doi. 10.1634/theoncologist.2019-0599
- By:
- Publication type:
- Article
Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High‐Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1413, doi. 10.1634/theoncologist.2018-0652
- By:
- Publication type:
- Article
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2621, doi. 10.1002/cncr.35302
- By:
- Publication type:
- Article
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1642, doi. 10.1002/cncr.35179
- By:
- Publication type:
- Article
Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors.
- Published in:
- Drugs & Aging, 2019, v. 36, n. 5, p. 395, doi. 10.1007/s40266-019-00644-1
- By:
- Publication type:
- Article
Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 764
- By:
- Publication type:
- Article
Detection of BRCA1 , and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3170, doi. 10.3390/biomedicines10123170
- By:
- Publication type:
- Article
Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.966534
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2143, doi. 10.3390/cancers16112143
- By:
- Publication type:
- Article
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5171, doi. 10.3390/cancers15215171
- By:
- Publication type:
- Article
Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3717, doi. 10.3390/cancers15143717
- By:
- Publication type:
- Article
Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2460, doi. 10.3390/cancers14102460
- By:
- Publication type:
- Article
Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4951, doi. 10.3390/cancers13194951
- By:
- Publication type:
- Article
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1199, doi. 10.1007/s11864-023-01107-x
- By:
- Publication type:
- Article
Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Neuroendocrine differentiation in usual‐type prostatic adenocarcinoma: Molecular characterization and clinical significance.
- Published in:
- Prostate, 2020, v. 80, n. 12, p. 1012, doi. 10.1002/pros.24035
- By:
- Publication type:
- Article
The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer.
- Published in:
- Prostate, 2017, v. 77, n. 13, p. 1303, doi. 10.1002/pros.23390
- By:
- Publication type:
- Article
Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study.
- Published in:
- Prostate, 2017, v. 77, n. 1, p. 33, doi. 10.1002/pros.23246
- By:
- Publication type:
- Article
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.
- Published in:
- Prostate, 2015, v. 75, n. 15, p. 1814, doi. 10.1002/pros.23064
- By:
- Publication type:
- Article
Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration.
- Published in:
- International Journal of Urology, 2017, v. 24, n. 6, p. 441, doi. 10.1111/iju.13346
- By:
- Publication type:
- Article
Incidence of Immune-Related Adverse Events with Program Death Receptor-1- and Program Death Receptor-1 Ligand-Directed Therapies in Genitourinary Cancers.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00056
- By:
- Publication type:
- Article